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INTRODUCTION 1 
Recurrent complex visual hallucinations are a core clinical feature of dementia with 2 
Lewy bodies (DLB) and are typically well-formed, often consisting of figures, such as 3 
people or animals (1). Despite the profound impact upon patients and caregivers in 4 
DLB, the aetiopathology of visual hallucinations remains largely unknown. In this 5 
article we discuss the anatomy of the human visual system, hypotheses of the genesis 6 
of visual hallucinations in DLB, and imaging and neuropathological studies that have 7 
attempted to understand visual hallucinations on a functional and anatomical basis. 8 
 9 
THE HUMAN VISUAL SYSTEM  10 
Human visual input comes from the eye, where light is transduced by the 11 
photoreceptors of the retina and transmitted along the optic nerve. Retinal ganglion 12 
cells, whose axons comprise the optic nerve, transmit a neural representation of the 13 
observed visual field to the lateral geniculate nucleus (LGN) of the thalamus, the 14 
primary subcortical relay centre between the retina and visual cortex. The visual cortex 15 
then sends ascending visual information to one of two parallel post-striate pathways: 16 
one projecting dorsally, which is involved in spatial and movement perception, and 17 
one projecting ventrally, which is implicated in object perception (2).  18 
An additional ‘secondary’ visual pathway originates in the retina, and projects parallel 19 
to the ‘primary’ retina-LGN-primary visual cortex pathway (3). The secondary visual 20 
pathway projects from the retina to the superior colliculus and then innervates the 21 
pulvinar nucleus of the thalamus. From the pulvinar, one pathway continues to visual 22 
areas involved in motion processing. Another pathway from the pulvinar projects to 23 
widespread targets, including the cingulate gyrus, amygdala and insular cortex, and is 24 
thought to integrate sensory inputs with limbic influences.  25 
 26 
HYPOTHESES OF VISUAL HALLUCINATIONS 27 
A key theme in visual hallucinations research has been the role of ‘bottom-up’ 28 
stimulus-driven contributors to visual hallucinations, and ‘top-down’ or expectancy and 29 
experience driven influences on visual hallucinations. Several hypotheses have been 30 
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proposed, some of which are exclusively based on bottom-up or top-down influences, 1 
and others that have aimed to incorporate both in a single model (4). 2 
 3 
Cortical release 4 
This hypothesis suggests that visual hallucinations may occur due to impaired or 5 
degraded visual input resulting in compensatory changes in excitability in the afferent 6 
visual pathway from the retina to the primary visual cortex. This hypothesis has been 7 
based, to some extent, on the observation that hallucinations often occur in visually 8 
impaired but cognitively normal individuals in a phenomenon termed Charles Bonnet 9 
syndrome. However, phenotypic overlaps in the phenomenology between individuals 10 
with DLB and Charles Bonnet suggest this may also be applicable to DLB. In this 11 
hypothesis, impairments of retinal input, or in the visual pathway between the retina 12 
and primary visual cortex, contribute to a compensatory reduction in visual cortical 13 
inhibition and corresponding increases in excitability (4). Under this proposed model, 14 
reduced inhibition, perhaps by compensatory changes to gamma-aminobutyric acid 15 
(GABA), contributes to increased visual cortical excitability underlying hallucinations 16 
(5).  17 
 18 
Activation-Input-Modulation model 19 
Consciousness is proposed to be regulated by three factors of activation, input and 20 
modulation. Activation is information processing capacity, input involves gating the 21 
balance between external stimuli and internal representations, and modulation 22 
integrates both activation and input over time. In DLB, it is thought that input is altered, 23 
perhaps by impaired dopaminergic modulation of the retina, inducing the release of 24 
normally blocked internal representations of external objects and the experience of 25 
hallucinations, particularly misperceptions (4). 26 
 27 
Blind to blindsight 28 
The secondary visual pathway, routed through the superior colliculus and pulvinar, is 29 
thought to mediate blindsight, the phenomenon of reacting to moving and affective 30 
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stimuli in the absence of conscious perception. Impairment of the pathway underlying 1 
blindsight has been directly implicated in visual symptoms of Lewy body disease (3), 2 
as this pathway encodes important accessory information, such as motion, about the 3 
observed visual scene that helps direct cognitive resources such as attention, rather 4 
than information about the observed scene (4). Dysfunction of this pathway could 5 
deprive the visual system of important accessory visual information, contributing to an 6 
over-reliance on top-down influences such as prior expectations that may also be 7 
dysfunctional in DLB.  8 
 9 
The dorsal attentional network 10 
Another account of visual hallucinations suggests that DLB patients may have difficulty 11 
in engaging the dorsal attention network to direct attention towards novel visual stimuli 12 
on the basis of salience and behavioural relevance (6). Instead they rely on the self-13 
referential default mode network, a brain network involved in self-referential and 14 
memory retrieval, thus biasing the visual system toward ‘top-down’ influences on 15 
perception.  16 
 17 
Perception and attention deficit 18 
Normal visual perception is thought to be a complex interplay between visual input 19 
and internal top-down representations of objects and visual scenes termed proto-20 
objects, formed as a result of experience and deployed on the basis of expectations 21 
(7). The Perceptual and Attention Deficit model suggests that deficient visual input and 22 
attention bias the visual system to the selection of incorrect proto-objects. Crucially, 23 
the visual scene remains intact, thus the hallucinated object is congruent with the 24 
visual scene, as observed in DLB (4). 25 
 26 
NEUROIMAGING STUDIES IN DLB  27 
To investigate the afferent visual pathway we examined the LGN, the primary thalamic 28 
relay structure between the retina and visual cortex, using a cohort of patients who 29 
were imaged using functional magnetic resonance imaging (fMRI) in response to 30 
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flashing checkerboard visual stimuli (8). This study demonstrated no significant 1 
difference between control and DLB cases in response to the observed stimulus, 2 
suggesting the major relay structure between the retina and primary visual cortex is 3 
intact. 4 
In the primary visual cortex, we used the phenomenon of phosphenes – flashes of 5 
light elicited by transcranial magnetic stimulation (TMS) over the occiput – to 6 
investigate cortical excitability in DLB (9). This study demonstrated no differences 7 
between DLB cases and controls in the degree of stimulation necessary to elicit 8 
phosphenes, as a surrogate of cortical excitability. However, visual hallucination 9 
severity was correlated with the degree of stimulation necessary to elicit phosphenes 10 
(9). Using a combination of TMS and blood oxygen level dependent (BOLD) fMRI in 11 
response to visual stimuli, we observed phosphene threshold was positively correlated 12 
with BOLD activity in early visual areas in aged control cases (10). This observation 13 
intuitively implies that individuals with sensitive visual systems require less stimulation 14 
to respond to an observed stimulus. However, we observed the opposite relationship 15 
in DLB, suggesting this dynamic has broken down. In controls, the positive relationship 16 
between BOLD activity (a summative measure of both excitatory and inhibitory activity) 17 
and phosphene threshold (a function of the balance between inhibitory and excitatory 18 
activity) means inhibition must outweigh excitation, whereas in DLB, this would mean 19 
inhibition is reduced relative to excitation.     20 
Fewer neuroimaging studies have evaluated the secondary visual pathway. However, 21 
our collaborators Marco Onofrj and Laura Bonnani have demonstrated a relationship 22 
between increased diffusivity of particular sub-regions of the pulvinar, as a marker of 23 
reduced tissue integrity, and clinical markers of the severity and frequency of visual 24 
hallucinations (11). 25 
 26 
NEUROPATHOLOGICAL STUDIES ON THE VISUAL SYSTEM IN DLB 27 
Histological studies 28 
The characteristic neuropathological feature of DLB is the presence of 29 
intracytoplasmic inclusions of aggregated α-synuclein, termed Lewy bodies, within 30 
vulnerable neurons (1). Amyloid-β and tau are also frequently observed in brains of 31 
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individuals with DLB and, although not a diagnostic feature, may influence the clinical 1 
phenotype.  2 
Post-mortem analysis of the LGN of aged control, DLB and AD cases using 3 
stereological assessment of neuronal number and densitometry to determine the 4 
extent of neuropathological lesion formation, indicated no significant difference 5 
between control and DLB cases. Notably, there was a complete absence of Lewy body 6 
pathology in all cases. In contrast, non-hallucinating AD cases (four tau Braak V and 7 
three Braak VI) had a significant reduction in parvocellular neuron number in the LGN 8 
compared to control cases (8). In the primary visual cortex we reported an absence of 9 
Lewy body pathology, neuronal loss and atrophy in DLB cases compared to aged 10 
controls (12). In contrast, we demonstrated atrophic neuronal soma in layer four of the 11 
primary visual cortex, the layer that receives input from the LGN, in non-hallucinating 12 
AD cases (five tau Braak V and six Braak VI) compared to controls.  13 
Our post-mortem analysis of the superior colliculus demonstrated that it is affected by 14 
Lewy body pathology and this was concentrated in the intermediate and deep layers, 15 
with the superficial layer largely spared, and neuronal loss only affecting the 16 
intermediate layer (13). AD cases had neuronal loss in all layers of the superior 17 
colliculus. The superficial layer of the superior colliculus has connectivity with both the 18 
LGN and visual cortex, both of which are typically spared Lewy body pathology and 19 
neuronal loss in DLB (8, 12). In contrast, the intermediate layer of the superior 20 
colliculus has an important role in visual target selection and directing visual attention 21 
towards behaviourally salient objects. Therefore, these results are consistent with our 22 
findings from the LGN and visual cortex, with DLB cases showing specific neuronal 23 
loss in non-primary visual regions compared to more widespread neuronal loss in AD.  24 
We have also reported mild Lewy body pathology in the pulvinar as particularly 25 
affecting the medial aspect of the nucleus (14). However, neuronal loss as determined 26 
by stereology was specifically found in the lateral aspect, a sub-region connected to 27 
the primary visual cortex  that strongly regulates visual cortical activity on the basis of 28 
attentional demands (15). Although AD cases also had neuronal loss in the lateral 29 
pulvinar, DLB had a greater degree of neuronal loss than AD cases in the lateral 30 
pulvinar, a notable finding in a stereological study conducted outside of the midbrain 31 
(16). 32 
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Overall, these studies have demonstrated relatively specific topographies of Lewy 1 
body pathology and neuronal loss in the visual system in DLB, with neurodegeneration 2 
particularly apparent in areas involved in regulating visual perception, particularly with 3 
regard to attention. In contrast, Alzheimer’s disease (AD) cases had more widespread 4 
neuronal loss and AD-type pathology was more widely distributed throughout the 5 
visual system. In DLB cases, Lewy body pathology and neuronal loss was typically 6 
found in secondary visual pathway structures, namely the superior colliculus and 7 
pulvinar, rather than in the LGN and primary visual cortex of the primary visual 8 
pathway. 9 
 10 
Molecular studies 11 
Although we have reported the primary visual cortex as spared histological signs of 12 
neurodegeneration post-mortem (12), there is physiological evidence from patients 13 
that it is functionally altered in DLB in a manner permissive to the genesis of visual 14 
hallucinations (9, 10). To explore changes to the primary visual cortex in DLB, we 15 
obtained tissue homogenates from DLB cases post-mortem for DNA microarray 16 
analysis. Microarray and subsequent confirmatory RNA and protein analyses 17 
demonstrated alterations to proteins involved in synaptic transmission, particularly 18 
involving reductions in the inhibitory neurotransmitter gamma aminobutyric acid 19 
(GABA) (12). We speculated that GABA-ergic changes may be a downstream result 20 
of neurodegeneration elsewhere, with the aim of compensating for altered input to the 21 
primary visual cortex. Our finding of reduced inhibitory activity in the visual cortex in 22 
DLB post-mortem is consistent with our previous findings of decreased excitability in 23 
the visual cortex intra vitam (9).        24 
Although we have reported neuronal loss in the pulvinar in DLB (14), and others have 25 
reported a relationship between pulvinar degeneration and visual hallucinations (11), 26 
Lewy body pathology in this area is relatively mild and the sub-regions most severely 27 
affected by α-synuclein aggregation did not manifest neuronal loss. Therefore, it is 28 
difficult to attribute the neuronal loss in the pulvinar to the manifest burden of Lewy 29 
body pathology. Therefore, we speculated that other factors must account for the 30 
reported neurodegeneration. RNA sequencing analysis of tissue lysates from the 31 
pulvinar, followed by confirmatory protein quantification assays and histology, 32 
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demonstrated profound reductions to synaptic markers and increases in reactive 1 
astrocytic proteins (17). We observed no relationship between astrocytic markers and 2 
Lewy body pathology but we did find a negative association between synaptic and 3 
astrocytic markers. As the pulvinar is a cerebral hub region that receives input from 4 
across the cortex, we speculated that alterations to the pulvinar result from 5 
neurodegenerative changes elsewhere. Reactive astrocytes have been previously 6 
reported in regions with high densities of Lewy bodies in Lewy body disease and may 7 
be activated by the actions of α-synuclein on currently unidentified receptors. 8 
Nevertheless, α-synuclein can activate astrocytes, inducing release of pro-9 
inflammatory cytokines, such as TNF-α, IL-1β, IL-2 and IL-4, creating a toxic 10 
environment for synaptic organisation and function (18).    11 
In summary, despite relatively low or absent levels of neurodegenerative pathology, 12 
the pulvinar and primary visual cortex manifest substantial changes on the molecular 13 
level in DLB. In both instances we suggest there is evidence to indicate that such 14 
changes, which are proposed to contribute to visual hallucinations, occur as a 15 
downstream result of neurodegenerative pathological changes elsewhere in the brain. 16 
 17 
DISCUSSION 18 
Our studies of the subcortical visual pathways have demonstrated relatively specific 19 
topographies of Lewy body pathology and neuronal loss in the visual system in DLB 20 
(Figure 1). In contrast, Alzheimer’s disease (AD) cases had more widespread neuronal 21 
loss and AD-type pathology was more widely distributed throughout the visual system. 22 
In DLB cases, Lewy body pathology and neuronal loss was typically found in 23 
secondary visual pathway structures, namely the superior colliculus and pulvinar, 24 
compared to the LGN and primary visual cortex of the primary visual pathway. 25 
However, despite low or absent levels of Lewy body pathology in the pulvinar and 26 
primary visual cortex, both regions manifested substantial changes on the molecular 27 
level in DLB brain tissue which were consistent with functional findings obtained intra 28 
vitam.  29 
The absence of Lewy body pathology or neuronal loss in a particular brain region does 30 
not necessarily imply it is physiologically intact. If visual hallucinations result purely 31 
from degeneration of the visual system, then one would expect visual hallucinations 32 
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to be at least as frequent in AD as they evidence more widespread patterns of 1 
pathological changes, yet visual hallucinations are more commonly found in DLB than 2 
AD. Therefore, we suggest that visual hallucinations in DLB are not simply the result 3 
of the observed pattern of degeneration within the visual system, but also physiological 4 
changes that occur to regions spared neurodegeneration. For example, whilst we 5 
noted an absence of Lewy body pathology and neuronal loss in the visual cortex in 6 
DLB (12), we observed alterations to markers of inhibitory neurotransmission post-7 
mortem and increased excitability in this region intra vitam that correlated with the 8 
severity of visual hallucinations (9, 10). Furthermore, we observed neuronal and 9 
synaptic loss in the pulvinar (14, 17), a region that regulates visual cortical activity, 10 
demonstrating a potential mechanism for how degeneration of a regulatory structure 11 
may induce physiological changes to the regions whose activity it regulates. 12 
In the superior colliculus, we demonstrated that neuronal density in the superficial 13 
layer of the superior colliculus, a region typically spared Lewy body pathology, was 14 
positively correlated with clinical markers of the severity and frequency of 15 
hallucinations (13). Whilst counterintuitive, the relative preservation of the superficial 16 
layer, in the context of neuronal loss in the intermediate layer, may contribute a 17 
vulnerability to visual hallucinations. The superficial layer receives feedback 18 
modulation through vertical pathways from the intermediate and deep layers, which 19 
can enhance or inhibit responses to observed visual stimuli. As a result, the superficial 20 
layer may erroneously enhance or inhibit visual responses due to altered modulatory 21 
influences from the dysfunctional intermediate layer.  22 
Since functional changes in non-degenerated brain regions may be permissive, and 23 
widespread degeneration prohibitive, to the generation of visual hallucinations, a key 24 
question is why some brain regions are not subject to neurodegenerative pathology in 25 
DLB. Pathological vulnerability may be explained in the context of a ‘prion-like’ spread 26 
of pathology originating at a predilection site and spreading on the basis of anatomical 27 
connectivity. However, some regions highly interconnected with early predilection 28 
sites do not typically manifest Lewy body pathology (19), indicating that anatomical 29 
connectivity is not the sole determinant of vulnerability. We have recently 30 
demonstrated that the primary visual cortex, a region with remarkable resilience to 31 
Lewy body formation, contains strikingly lower levels of physiological α-synuclein in 32 
the brains of the cognitively intact elderly post-mortem (20). Therefore, normal 33 
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expression levels of physiological α-synuclein may contribute to the topography of 1 
regions that are resilient to Lewy body formation but which nonetheless remain 2 
vulnerable to physiological changes resulting from degeneration elsewhere.   3 
Overall, the combination of our physiological and neuropathological studies indicate 4 
that a particular pattern of preserved and impaired functionality may be needed in 5 
order to generate visual hallucinations. All of the models reviewed earlier suggest 6 
combined changes in several aspects of visual processing are necessary for these 7 
phenomena. This overlap between pathological findings and modelling suggests that 8 
this will be a fruitful approach to explore in future research studies.          9 
 10 
CONCLUSION 11 
The visual system shows relatively focal neurodegeneration in DLB. The specific 12 
topography of degeneration, and physiological changes in pathologically ‘preserved’ 13 
regions, may both be critical to the manifestation of visual hallucinations. Pathological 14 
susceptibility may be mediated by numerous factors, but physiological α-synuclein 15 
expression levels appear important. In AD, more widespread degeneration of the 16 
visual system may preclude physiological dysfunction due to a lack of anatomically 17 
preserved but physiologically altered regions necessary to elicit visual hallucinations. 18 
These findings suggest that evaluation of regions beyond those with high burdens of 19 
Lewy body pathology may be important to identify changes that may occur 20 
downstream of neurodegeneration, but may be critical to the manifestation of visual 21 
hallucinations. 22 
 23 
 24 
 25 
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